# GPT-5-mini Review

**Role:** External referee review
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-11T14:46:42.772705
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 18425 in / 6089 out
**Response SHA256:** 0573a4e3cb02dd7e

---

Thank you for the opportunity to review this carefully conceived and important paper. The question—do state laws mandating school-based suicide-prevention (gatekeeper) training reduce suicide mortality?—is policy-relevant and meritocratic. The author assembles plausible data, uses modern staggered-DiD methods (Callaway–Sant’Anna), and provides a detailed set of robustness checks. At the same time, there are several substantive and presentation issues that must be addressed before this manuscript is ready for a top general-interest or policy journal. Below I provide a comprehensive review organized around the requested headings: format, statistical methodology, identification strategy, literature, writing quality, constructive suggestions, overall assessment, and a final decision.

1. FORMAT CHECK

- Length: The LaTeX source and appended materials indicate a full paper with substantive appendix. Based on the content provided, the manuscript (main text + appendix) appears to exceed 25 pages (roughly 30–50 pages depending on formatting). This satisfies the length expectation for a top-journal submission.

- References: The bibliography (as cited in text) covers many relevant empirical and policy sources (CDC, program evaluations, reviews) and it cites several modern DiD papers (Callaway & Sant’Anna, Goodman-Bacon, Sun & Abraham, de Chaisemartin). However:
  - A few canonical methodological works that are highly relevant to staggered DiD and inference are missing from the bib file in the source you provided (see Section 4 below where I list specific papers I recommend adding with BibTeX).
  - The policy-related literature on suicide prevention, school-based interventions, and community interventions is touched on, but I recommend adding a couple more directly-relevant empirical and meta-analytic studies (see suggestions below).

- Prose: Major sections (Introduction, Institutional Background, Conceptual Framework, Data, Empirical Strategy, Results, Discussion, Conclusion) are written in paragraph form, not bullets. Good.

- Section depth: Most major sections contain multiple substantive paragraphs. The Introduction, Data, Empirical Strategy, Results, and Discussion are well developed with 3+ paragraphs each. Institutional Background and Conceptual Framework are adequate. Appendix sections are appropriately detailed.

- Figures: The LaTeX source references a number of figures (event study, rollout map, trends, Bacon decomposition, placebo event studies, leave-one-out). The source uses \includegraphics for each. I could not visually inspect rendered figures from the .tex, but the captions and notes indicate that the figures display relevant data. Please ensure that when you submit a PDF all figures have legible axes, labels, units, and readable fonts in the final production stage.

- Tables: All tables in the source show numeric entries (no placeholders). Standard errors are included in tables (in parentheses) and sample sizes (observations, states) are reported. Good.

Summary: Format is generally acceptable; ensure final PDF has high-resolution figures and that the bibliography includes all necessary citations (see Section 4).

2. STATISTICAL METHODOLOGY (CRITICAL)

This is the most important section of my review. A paper cannot pass without sound statistical inference. I summarize what the authors do well and what must be fixed/clarified.

What the paper does correctly
- Uses the Callaway & Sant’Anna (2021) group-time ATT estimator for staggered adoption, explicitly avoiding TWFE biases. This is appropriate and necessary given dynamic treatment effects.
- Reports clustered standard errors in main tables and presents 95% CIs and p-values. The main table (Table: Effect...) includes SEs in parentheses, CIs and p-values.
- Reports sample sizes (observations, number of states, number of treated states).
- Performs placebo outcomes (heart disease, cancer) and a Goodman–Bacon decomposition to illustrate TWFE bias.
- Conducts leave-one-cohort-out sensitivity checks and reports wild cluster bootstrap p-values.

Required clarifications / remaining issues (critical)
a) Standard errors / inference for event-study coefficients:
   - The event-study figure is central to the paper’s story (null short-run, negative long-run emerging at e≥6). Show the numerical event-study coefficients with standard errors and CIs in a table (not only in the figure). Readers and referees must be able to see the SEs and numbers for each event time. I see SEs referenced in text (e.g., e=10 SE=0.36), but please present a full numeric event-study table in main text or appendix.
   - The event-study long-run points (e.g., e=10) are identified by very few treated units (event-time-contribution table indicates e=10 is identified by a single state—New Jersey). Cluster-robust SEs assume many independent clusters; when effective treated clusters are few the usual clustered SEs may be unreliable. The paper mentions wild cluster bootstrap and permutation but uses it sparsely. For event-time estimates with small numbers of treated units, you must report alternative inference:
     - Conduct randomization/permutation inference that reassigns cohort labels (or treatment years) in a way that preserves time series structure and compute p-values for each event-time coefficient.
     - Use the wild cluster bootstrap for the event-study coefficients (not only for TWFE). Report bootstrap p-values and explain how many clusters were treated/controls in each bootstrap iteration.
     - Consider using the “placebo cohort” or “leave-k-out” synthetic inference to check whether similar long-run patterns appear when you artificially shift treatment dates.
   - If the long-run effect (e=10) is primarily from a single treated state, label it clearly as suggestive exploratory evidence and avoid strong claims. Provide inference that conditions on few treated clusters (e.g., Abadie et al.-style synthetic control or inference tailored to single-case studies, see suggestions).

b) Control group choice and not-yet-treated controls:
   - The manuscript uses not-yet-treated controls (Callaway–Sant’Anna default). This is defensible, but the properties of not-yet-treated controls can be sensitive if anticipation occurs or if not-yet-treated states trend differently. You perform a never-treated-only robustness check (ATT nearly identical), which is reassuring. Still, I recommend:
     - Report how many never-treated states are used (you state 26 states + DC—this is 26 units; the numbers should be consistent across text/tables).
     - Present event-study estimates that use only never-treated controls as an alternative; compare pre-trends visually to the main specification.
     - If you use both groups in different specifications, explain precisely what “NYT” refers to in Table 1 and the event study (not-yet-treated vs never-treated).

c) Multiple testing / joint tests:
   - You report several event-time coefficients. Present a joint pre-trend test (F-test or equivalent) that the entire pre-treatment vector equals zero (the Callaway & Sant’Anna framework permits such tests). You mention pre-treatment coefficients are “small and insignificant,” but a formal joint test should be shown in the appendix (with p-value).
   - For the post-treatment period, consider reporting confidence bands that control familywise error rate (e.g., using uniform confidence bands or bootstrap-based multiple testing corrections) so readers know how robust the pattern is across event times.

d) Heterogeneous effects and cohort attrition:
   - The paper correctly notes that at long horizons few cohorts contribute. This attrition is inherent, but the paper must present cohort-specific ATTs (or at least cohort-level event studies for early cohorts) rather than only aggregated ATT(e). Show ATT(g,t) for the earliest cohorts (e.g., New Jersey, Tennessee) separately. If the main long-run evidence rests on New Jersey, present a New Jersey-specific time series comparison using synthetic control or SCM-in-time to validate the claim.
   - When you present cohort-specific estimates, include SEs and discuss their degrees of freedom.

e) Power calculations:
   - The paper draws strong conclusions from an overall null. Provide a statistical power calculation showing the minimum detectable effect (MDE) for the main specification (with 51 clusters over 19 years). You give confidence intervals but the reader benefits from an explicit MDE (e.g., the paper can rule out reductions greater than X per 100,000 with 80% power). This helps interpret the meaningfulness of a null result.

f) Robustness of standard error clustering:
   - You cluster at the state level (correct). But because treatment varies at the state level and there are only 25 treated clusters, the small number of treated clusters could bias SEs. You already use wild cluster bootstrap as a robustness check, but you should present those results for your primary CS-ATT and for key event-time coefficients (especially e≥6). Also consider two-way clustering (state × year) is unnecessary here, but mention why.

g) Potential omitted confounders / time-varying controls:
   - You control for Medicaid expansion, which is good. However, other contemporaneous policy changes may confound trends in suicide: state-level firearm policy changes, opioid-prescribing restrictions, naloxone distribution, mental health parity laws, school counselor hiring initiatives, economic shocks (state unemployment), and state-level drug overdose trends (opioid epidemic). At the very least, discuss these omitted policies; ideally include a set of time-varying controls (or show that adoption timing is uncorrelated with changes in these policies). If data permit, augment the main specification with controls for:
     - State unemployment rate, poverty rate
     - Firearm laws proxy (e.g., presence of “shall issue/permit” or background check changes)
     - Opioid overdose rates or policy adoptions (PDMPs)
   - Demonstrate that adding these controls does not meaningfully change the CS-ATT or the event-study trajectory.

h) Measurement: the dilution problem
   - The manuscript rightly notes that the outcome is the all-age suicide rate, which dilutes youth-specific effects. This is a major limitation. The author identifies pursuit of age-specific data (CDC WONDER restricted files or state vital records) as a priority. The current analysis must be explicit about how dilution affects interpretation. If possible, compute a back-of-envelope conversion from observed all-age effect to youth effect (you do this) and present explicit bounds or sensitivity analysis.

Bottom line on methodology: The paper uses appropriate modern estimators, reports SEs, and runs multiple robustness checks. However, the long-run event-study claims hinge on small numbers of treated units; the paper must add dedicated inference for sparse-treated settings (bootstrap/permute), cohort-specific analyses (including synthetic control for early adopters), a power analysis, and additional controls or placebo policies to convincingly rule out confounding. Without these, the long-run claim is suggestive at best.

3. IDENTIFICATION STRATEGY

- Credibility: The identification strategy—staggered adoption exploited via Callaway–Sant’Anna with not-yet-treated controls—is appropriate. The key identifying assumption is parallel trends. The manuscript provides visual evidence (group means) and the event-study pre-treatment coefficients that support parallel trends. This is good.

- Assumptions discussed: The paper discusses parallel trends, no anticipation, and dilution. It also acknowledges selection into treatment and concurrent policies (Medicaid expansion). This discussion is thoughtful.

- Placebo tests and robustness: Placebo outcomes (heart disease, cancer) are a useful check and appear to show null effects. However, I recommend additional placebo tests:
  - Use “falsified” treatment years (randomly assign treatment years to the treated states) and show the distribution of treatment effect estimates under random assignments. This will help assess whether the event-study pattern could arise by chance.
  - Use outcomes plausibly affected in the opposite direction (e.g., suicide attempts if available, emergency department visits for self-harm) if accessible, or show no effect on unrelated causes (you do for heart disease and cancer).
  - Test for pre-policy changes in training rates or school counselor hiring around adoption to rule out anticipation via other channels.

- Do conclusions follow evidence? The paper carefully states a precise null for short-run overall ATT and frames the long-run decline as suggestive (but at times the prose reads stronger than warranted). Because the e=10 result largely rests on New Jersey, the paper should soften causal claims about a general long-run effect until corroborated by age-specific analyses or extended data.

- Limitations: The author states key limitations (age-specific data unavailable, small number of cohorts at long horizons, measurement of completed suicides only). These are important and appropriately acknowledged, but the paper should do more to quantify how these limitations affect inference (e.g., MDEs, sensitivity bounds).

4. LITERATURE (Provide missing references)

The paper cites many relevant papers (Callaway & Sant’Anna 2021, Goodman-Bacon 2021, Sun & Abraham 2021, de Chaisemartin & D’Haultfoeuille). Still, I recommend explicitly citing the following methodological and policy-relevant works that are highly relevant and likely expected by referees:

Methodology / staggered DiD / inference:
- Borusyak, Jaravel, & Spiess (2021) on design-based DiD and related estimators (helps position Callaway–Sant’Anna among alternatives).
- Abadie, Diamond & Hainmueller (2010) and Abadie et al. work on synthetic control (for validating early-adopter long-run results).
- Imbens & Lemieux (2008) and Lee & Lemieux (2010) for RDD methods (you do not use RDD here, but referees often expect canonical citations when discussing identification alternatives).

Policy and empirical suicide-prevention literature:
- Knox et al. (2003) community-based suicide prevention (author references Knox 2003 in text but ensure full citation).
- Zalsman et al. (2016) meta-analysis on suicide prevention (cited?).
- Other recent evaluations of gatekeeper training and school-based suicide prevention that attempt youth-level outcomes if any (cite systematic reviews and any U.S. state-level program evaluations).

Below are BibTeX entries for several key methodological papers the author should include. Please add any of these that are missing to the references and cite them in relevant parts of the paper (methods, robustness, synthetic control discussion, and place where you discuss alternative estimators).

- Goodman-Bacon (already cited in text but include full bib if missing)
- Sun & Abraham (already cited)
- de Chaisemartin & D’Haultfoeuille (already cited)
- Borusyak, Jaravel & Spiess (2021)
- Abadie, Diamond & Hainmueller (2010)
- Imbens & Lemieux (2008)
- Lee & Lemieux (2010)

BibTeX entries (add these to your references.bib if not already present):

```bibtex
@article{goodmanbacon2021,
  author = {Goodman-Bacon, Andrew},
  title = {Difference-in-Differences with Variation in Treatment Timing},
  journal = {Journal of Econometrics},
  year = {2021},
  volume = {225},
  pages = {254--277}
}

@article{callaway2021,
  author = {Callaway, Brantly and Sant'Anna, Pedro H. C.},
  title = {Difference-in-Differences with Multiple Time Periods},
  journal = {Journal of Econometrics},
  year = {2021},
  volume = {225},
  pages = {200--230}
}

@article{sunandabraham2021,
  author = {Sun, Liyang and Abraham, Stefann},
  title = {Estimating Dynamic Treatment Effects in Event Studies with Heterogeneous Treatment Effects},
  journal = {Journal of Econometrics},
  year = {2021},
  volume = {225},
  pages = {175--199}
}

@article{deChaisemartin2020,
  author = {de Chaisemartin, Cl\'{e}ment and D'Haultf{\oe}uille, Xavier},
  title = {Two-Way Fixed Effects Estimators with Heterogeneous Treatment Effects},
  journal = {American Economic Review},
  year = {2020},
  volume = {110},
  pages = {296--304}
}

@article{borusyak2021,
  author = {Borusyak, Kirill and Jaravel, Xavier and Spiess, Jann},
  title = {Revisiting Event Study Designs: Robust and Efficient Estimation},
  journal = {arXiv preprint arXiv:2011.04732},
  year = {2021}
}

@article{abadie2010,
  author = {Abadie, Alberto and Diamond, Alexis and Hainmueller, Jens},
  title = {Synthetic Control Methods for Comparative Case Studies: Estimating the Effect of California's Tobacco Control Program},
  journal = {Journal of the American Statistical Association},
  year = {2010},
  volume = {105},
  pages = {493--505}
}

@article{imbens2008,
  author = {Imbens, Guido and Lemieux, Thomas},
  title = {Regression Discontinuity Designs: A Guide to Practice},
  journal = {Journal of Econometrics},
  year = {2008},
  volume = {142},
  pages = {615--635}
}

@article{lee2010,
  author = {Lee, David S. and Lemieux, Thomas},
  title = {Regression Discontinuity Designs in Economics},
  journal = {Journal of Economic Literature},
  year = {2010},
  volume = {48},
  pages = {281--355}
}
```

Why each is relevant:
- Goodman-Bacon and de Chaisemartin explain TWFE pathologies and decomposition used in your paper.
- Callaway & Sant’Anna and Sun & Abraham are the heterogeneity-robust DiD estimators used—cite full refs and implementation details (software packages).
- Borusyak et al. offer recent perspectives on event-study design and robust estimation that could strengthen your methodological appendix and inference choices.
- Abadie et al. (synthetic control) provide a complementary single-unit inference approach that is ideal for validating the long-run New Jersey result.
- Imbens & Lemieux and Lee & Lemieux are canonical references for continuity/identification (if you mention RDD or alternative identification approaches).

5. WRITING QUALITY (CRITICAL)

Overall assessment: The manuscript is well-written, clear, and readable. The introduction motivates the question with a humanizing story, situates the policy, and states the results concisely. Most sections are organized logically and present the intuition, methods, and results coherently.

Detailed feedback:

a) Prose vs. bullets: Major sections are written in full paragraphs. Bulleted lists are used only for data/variable descriptions. Good.

b) Narrative flow: Strong. The Introduction moves from anecdote to national trend to policy and to empirical approach, which is exactly the arc you want. The transition from null overall ATT to dynamic event-study story is logical and well motivated.

c) Sentence quality: Mostly crisp, but occasionally the prose overstates what the evidence supports (e.g., claiming the e=10 estimate “represents a 13% reduction” is fine, but avoid emphasizing statistical significance too strongly when that estimate is identified by a single state). Use more hedging for long-run claims and be explicit about which results are exploratory.

d) Accessibility: Mostly accessible to non-specialists in economics policy journals. A few technical econometric terms (e.g., not-yet-treated, group-time ATT) are used—explain briefly for broader readership. The conceptual framework (equation 1) is useful; consider adding further intuition for Callaway–Sant’Anna and for the Goodman–Bacon decomposition in plain language.

e) Tables and notes: Table and figure captions are informative. Ensure all abbreviations (ATT, CS-ATT, NYT) are defined in table notes. In Table 1 the “Control Group: NYT” label should be defined in the table notes (you do so elsewhere but make table self-contained).

f) Authorship disclaimer: The paper states it was “autonomously generated." This will raise red flags for editors and referees regarding reproducibility and data/code provenance. Be explicit about what “autonomously generated” means: did the authors run analysis, or did a generative tool produce text? Provide fully reproducible code and a README and affirm human oversight and verification. Journals will require clarity on authorship and reproducibility.

Overall: Good writing; correct tone and structure. Tighten language around exploratory vs. confirmatory claims.

6. CONSTRUCTIVE SUGGESTIONS

If the goal is to make this paper publishable in a top general-interest or policy journal, here are concrete steps to strengthen it.

A. Acquire age-specific mortality data (highest priority)
- The major limitation is the use of an all-age suicide rate which dilutes youth effects. Pursue access to age-by-state vaccination of suicide deaths via:
  - CDC WONDER suppressed cells (may require restricted access or aggregated bins).
  - State vital statistics or restricted NCHS data (apply for access if possible).
- With age-specific data, implement a triple-difference (DiD-in-DiD) comparing youth (10–24 or 15–21) vs adults, treated vs controls, pre- vs post-policy. This directly addresses the dilution problem and would materially strengthen causal claims.

B. Strengthen long-run inference
- For the long-run (e≥6) dynamics, present cohort-specific event studies (ATT(g,t)) for each early adopter and synthetic-control validation for New Jersey and Tennessee:
  - Implement synthetic control for New Jersey (early adopter) to compare observed trend to synthetic control constructed from never-treated states, with placebo-in-space inference (Abadie et al. approach).
  - If SCM supports the event-study result, it bolsters the long-run claim even when only a few treated units identify large e.
- Use permutation inference and wild cluster bootstrap for each event-time coefficient, report bootstrap p-values for e≥6…10.

C. Additional robustness / controls
- Add time-varying controls: unemployment, poverty rate, opioid overdose rate (or PDMP implementation), firearm policy indices, state mental-health funding (if available).
- Show that adoption timing is not strongly correlated with trends in those controls pre-treatment.

D. Power and sensitivity analysis
- Add explicit MDE calculations (80% power) for the main sample for the overall ATT and for youth-targeted MDE (using plausible youth population shares).
- Conduct sensitivity checks to assess how large youth-specific effects would have to be to be detectable in the all-age rate.

E. Mechanisms: training uptake and fidelity
- If possible, include evidence on compliance: what share of school personnel actually completed training after mandates? The Jason Foundation or state education agencies may have compliance estimates. If you cannot get coverage rates, say so and discuss how low compliance would bias results toward zero.
- Discuss downstream capacity constraints: if schools refer students to mental health services but no providers are available, clinical referral channel will be limited. If data exist for school counselor-to-student ratios over time by state, show whether these changed around adoption.

F. Clarify treatment coding and timing
- Provide an appendix table with alternative treatment codings (effective year; first school-year; first calendar year) and show event study under each. You report one alternative, but show the event study sensitivity as well.
- Consider lag structures (immediate-year vs one-year-lag vs two-year-lag).

G. Present cohort-contributions neatly
- Add a table that shows, for each event-time, the contributing cohorts, number of treated states, and their weights in the ATT(e) aggregation. You include a version but make it explicit and linked to inference.

H. Presentation and reproducibility
- Provide complete replication code and data pipeline (you cite a GitHub repo). Ensure that code and data (to the extent allowed by data licenses) are available and that code reproduces all tables/figures.
- In the Methods appendix, list the exact software and package versions used (e.g., R version, did you use did package by Sant’Anna, fixest::sunab?).

7. OVERALL ASSESSMENT

Key strengths
- Addresses a clear and important policy question: mandatory school suicide-prevention training and mortality.
- Uses modern econometric tools (Callaway–Sant’Anna) and engages with recent literature on staggered DiD.
- Provides a careful sequence of robustness checks (placebo outcomes, alternative control groups, Goodman–Bacon decomposition).
- Well written and structured, with thoughtful discussion of mechanisms and policy implications.

Critical weaknesses (must be addressed)
- Long-run event-study evidence rests on very few treated units (e.g., e=10 identified by a single state) so standard cluster-robust inference may be unreliable. Additional inference (permutation/bootstrap), synthetic control validation for early adopters, and cohort-specific estimates are required to support long-run claims.
- Lack of age-specific outcomes is a major limitation: dilution of youth effects by the all-age rate limits the policy-relevant interpretation. Obtaining age-specific data or using triple-difference designs is the single biggest way to strengthen this study.
- Potential omitted time-varying confounders (firearm/opioid policies, economic shocks) are incompletely addressed; these should be considered in robustness checks.
- The unusual “autonomous generation” authorship statement needs clarification and full documentation of human oversight and reproducibility.

Specific suggestions for improvement (concise)
- Acquire age-specific suicide data and run a triple-difference focusing on youth.
- Perform synthetic control analysis for New Jersey (and Tennessee) to validate long-run e≥6 pattern.
- Provide permutation/wild-bootstrap inference for event-study coefficients and report numerical event-study table with SEs and bootstrapped p-values.
- Add additional time-varying controls (unemployment, opioid policy, firearm law indices) and demonstrate robustness.
- Provide power calculations (MDE) and explicitly quantify what effects the data can/cannot detect.
- Clarify authorship and reproducibility: provide accessible replication repo, code, and full documentation; if the paper used autonomous text-generation, disclose human editing and vetting steps.

8. DECISION (REQUIRED)

Given strengths and limitations, my recommendation is that the manuscript is promising but requires substantial additional analysis (notably age-specific estimation or strong single-case corroboration, and more robust inference for long-run results). Therefore, I recommend:

DECISION: MAJOR REVISION

(If the authors address the items above—obtain age-specific data or convincingly validate long-run patterns with synthetic control and permutation inference; add omitted policy controls and power calculations; and improve presentation and reproducibility—the paper could be appropriate for final acceptance.)